A serum inhibitor of immune regulation in patients with systemic lupus erythematosus.
Normal mononuclear leukocytes were incubated with serum from patients with active systemic lupus erythematosus (SLE) and healthy subjects and then studied on lymphoproliferative tests. Serum from SLE patients that contained an autoantibody to a subpopulation of thymus-derived (T) lymphocytes inhibit...
Spremljeno u:
| Izdano u: | J Clin Invest |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society for Clinical Investigation
1978
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC371819/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/308514/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI109180 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
